Cargando…
Role of the Spleen Tyrosine Kinase Pathway in Driving Inflammation in IgA Nephropathy
Summary: IgA nephropathy is the most common type of primary glomerulonephritis worldwide. At least 25% of patients may progress to kidney failure requiring dialysis or transplantation. Treatment of IgA nephropathy using generalized immunosuppression is controversial, with concerns regarding the bala...
Autores principales: | McAdoo, Stephen, Tam, Frederick W.K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
W.B. Saunders
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6135887/ https://www.ncbi.nlm.nih.gov/pubmed/30177021 http://dx.doi.org/10.1016/j.semnephrol.2018.05.019 |
Ejemplares similares
-
Primary IgA nephropathy: current challenges and future prospects
por: Penfold, Rose S, et al.
Publicado: (2018) -
Spleen Tyrosine Kinase Inhibition Ameliorates Tubular Inflammation in IgA Nephropathy
por: Yiu, Wai Han, et al.
Publicado: (2021) -
Spleen tyrosine kinase inhibition is an effective treatment for established vasculitis in a pre-clinical model
por: McAdoo, Stephen P., et al.
Publicado: (2020) -
Targeting the tyrosine kinase signalling pathways for treatment of immune-mediated glomerulonephritis: from bench to bedside and beyond
por: Ma, Terry King-Wing, et al.
Publicado: (2017) -
Inhibition of spleen tyrosine kinase decreases donor specific antibody levels in a rat model of sensitization
por: Tempest-Roe, Shenzhen, et al.
Publicado: (2022)